TheraRadar

Pharma Intelligence, Simplified

Landscape → Renal

Chronic Kidney Disease

581 clinical trials

205 active
/
581 total (since 2015)
36
Phase 1 Active
130 total
78
Phase 2 Active
210 total
59
Phase 3 Active
157 total
59
Phase 4 Active
136 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
AstraZeneca 8 19 3
Eli Lilly 5 3 1
Bayer 3 14 3
Novo Nordisk 2 6 1
Boehringer Ingelheim 2 3 1
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 2 2 0
Alebund Pharmaceuticals 2 2 0
Shandong Suncadia Medicine Co., Ltd. 2 1 0
United Therapeutics 2 0 0
Akebia Therapeutics 1 9 4
Prokidney 1 4 3
Amgen 1 4 1
Renibus Therapeutics, Inc. 1 3 0
Humacyte, Inc. 1 3 0
Zydus Lifesciences Limited 1 3 0
NCT05970172 RECRUITING
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Astellas Pharma Global Development, Inc. n=100
NCT06578078 RECRUITING
A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
Fundación para la Investigación del Hospital Clínico de Valencia n=94
NCT07355062 RECRUITING
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
Renibus Therapeutics, Inc. n=150
NCT07107945 RECRUITING
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Boehringer Ingelheim n=120
NCT07241390 RECRUITING
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Eli Lilly and Company n=7,140
NCT03633708 RECRUITING
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Amgen n=56
NCT06383390 ACTIVE NOT RECRUITING
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Eli Lilly and Company n=10,000
NCT07425262 NOT YET RECRUITING
A Pilot Trial of Chinese Medicine for Patients With Dialytic Hypotension
Chang Gung Memorial Hospital n=100
NCT05457283 RECRUITING
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Bayer n=100
NCT07025629 RECRUITING
Dapagliflozin for Cardio-renal Protection After ICU Discharge
Assistance Publique - Hôpitaux de Paris n=600
NCT06901505 ACTIVE NOT RECRUITING
To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis
Akebia Therapeutics n=353
NCT07419828 NOT YET RECRUITING
A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease
Shandong Suncadia Medicine Co., Ltd. n=1,978
NCT06742723 RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
AstraZeneca n=5,000
NCT05746559 ACTIVE NOT RECRUITING
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
Alexion Pharmaceuticals, Inc. n=736
NCT06087835 ACTIVE NOT RECRUITING
Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)
AstraZeneca n=1,835
NCT05196035 RECRUITING
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
Bayer n=219
NCT06933472 RECRUITING
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Alebund Pharmaceuticals n=264
NCT06268873 ACTIVE NOT RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
AstraZeneca n=2,554
NCT03323476 RECRUITING
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
Centre Hospitalier Departemental Vendee n=136
NCT05803421 ACTIVE NOT RECRUITING
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
Eli Lilly and Company n=2,749
NCT05099770 RECRUITING
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Prokidney n=685
NCT05422534 RECRUITING
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
Vanderbilt University Medical Center n=156
NCT07296146 NOT YET RECRUITING
Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.
Badr University n=80
NCT06058585 RECRUITING
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
The George Institute n=1,000
NCT05021835 ACTIVE NOT RECRUITING
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
Novo Nordisk A/S n=6,200
NCT05732727 RECRUITING
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
University Hospital, Tours n=720
NCT03969953 ACTIVE NOT RECRUITING
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease
The George Institute n=2,000
NCT05546099 RECRUITING
Patient-driven Management of BP in CKD
VA Office of Research and Development n=160
NCT07122401 RECRUITING
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
Shaanxi Micot Pharmaceutical Technology Co., Ltd. n=424
NCT07181135 NOT YET RECRUITING
FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors
University Medical Center Groningen n=180
NCT06866236 NOT YET RECRUITING
Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression
Ebima Clifford Okundaye n=3,000
NCT06858280 RECRUITING
Patiromer and Diet/hrQoL in Chronic Dialysis
Mario Negri Institute for Pharmacological Research n=40
NCT07119372 RECRUITING
Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Biocad n=228
NCT07020832 NOT YET RECRUITING
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
Apellis Pharmaceuticals, Inc. n=320
NCT06337838 RECRUITING
Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial
Hamilton Health Sciences Corporation n=100
NCT06908473 ENROLLING BY INVITATION
Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients
Guangdong Provincial Hospital of Traditional Chinese Medicine n=530
NCT05284656 ACTIVE NOT RECRUITING
Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease
Al-Azhar University n=80
NCT06998862 RECRUITING
Colchicine in Chronic Kidney Disease Patients
Hospital General Universitario Gregorio Marañon n=744
NCT06982079 RECRUITING
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease
Ain Shams University n=60
NCT03565913 ACTIVE NOT RECRUITING
Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V
University of Texas Southwestern Medical Center n=269
NCT03994471 RECRUITING
Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
Iperboreal Pharma Srl n=170
NCT05339139 RECRUITING
SAfety of Regional Citrate Anticoagulation (SARCA Study)
Fresenius Medical Care North America n=50
NCT06801886 ENROLLING BY INVITATION
Silymarin's Advantage on Graft Effectiveness
University Hospital, Martin n=130
NCT05908084 RECRUITING
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
Humacyte, Inc. n=150
NCT03321656 RECRUITING
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
Roberto Gedaly n=78
NCT02984124 ACTIVE NOT RECRUITING
Communication During Hospitalization About Resuscitation Trial
University of Vermont n=182
NCT06820567 NOT YET RECRUITING
Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients with Type 2 Diabetes and CKD
Assiut University n=210
NCT06520826 RECRUITING
Vafseo Outcomes In-Center Experience
USRC Kidney Research n=2,200
NCT06329622 RECRUITING
Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease
Huashan Hospital n=58
NCT05918029 RECRUITING
Bone in CKD Alkali Response (BICARb Pilot Trial)
Albert Einstein College of Medicine n=103
NCT05679024 RECRUITING
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Region Stockholm n=1,400
NCT03418779 ACTIVE NOT RECRUITING
Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD
Guang'anmen Hospital of China Academy of Chinese Medical Sciences n=60
NCT06578533 RECRUITING
Keeping RAASi Treatment With Optimal Potassium Control
Fundación para la Investigación del Hospital Clínico de Valencia n=78
NCT06352138 NOT YET RECRUITING
Comparative Study of Two Recombinant Human Erythropoietin Products in Chronic Kidney Disease Patients
Megalabs n=280
NCT03619850 RECRUITING
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
AMAG Pharmaceuticals, Inc. n=129
NCT06466785 RECRUITING
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Genexine, Inc. n=429
NCT06421883 ENROLLING BY INVITATION
Study the Effect of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Level in Hemodialysis Patients
Al-Azhar University n=80
NCT06421870 RECRUITING
Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients
Ain Shams University n=210
NCT05713851 RECRUITING
Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran n=100
NCT02251431 COMPLETED
Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
Baylor Research Institute n=57
NCT04523727 SUSPENDED
Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease
Keryx Biopharmaceuticals n=45
NCT05047263 COMPLETED
A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease
Bayer n=1,584
NCT04865770 COMPLETED
A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)
Novo Nordisk A/S n=106
NCT07344922 COMPLETED
SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia
Mansoura University n=100
NCT03402386 COMPLETED
Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
Tanabe Pharma Corporation n=42
NCT03439137 COMPLETED
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
Tanabe Pharma Corporation n=323
NCT03329196 COMPLETED
Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
Tanabe Pharma Corporation n=304
NCT03461146 COMPLETED
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
Tanabe Pharma Corporation n=24
NCT04064827 TERMINATED
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
AbbVie n=2
NCT04649411 WITHDRAWN
Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
Keryx Biopharmaceuticals
NCT03183245 COMPLETED
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis
Humacyte, Inc. n=242
NCT07030595 COMPLETED
AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia
Alebund Pharmaceuticals n=474
NCT05901831 COMPLETED
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes
Bayer n=241
NCT02513303 COMPLETED
Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
Vascular Therapies, Inc. n=269
NCT05082571 WITHDRAWN
Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease
Akebia Therapeutics
NCT05082584 WITHDRAWN
Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents
Akebia Therapeutics
NCT05425056 COMPLETED
A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery
Vascular Therapies, Inc. n=136
NCT04968184 TERMINATED
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)
KBP Biosciences n=652
NCT06381076 COMPLETED
High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.
University of Florida n=35
NCT02859896 TERMINATED
Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis
Sanofi n=21
NCT05543928 TERMINATED
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
OPKO Health, Inc. n=2
NCT03594110 COMPLETED
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Boehringer Ingelheim n=6,609
NCT04543812 COMPLETED
PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD
Panion & BF Biotech Inc. n=141
NCT07023016 COMPLETED
Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure
National Heart Institute, Egypt n=515
NCT03749447 TERMINATED
An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)
Biogen n=270
NCT02644941 COMPLETED
Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis
Humacyte, Inc. n=355
NCT05998837 COMPLETED
GLUcose Transport and REnalPROtection in Chronic Kidney Disease
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy n=34
NCT05585645 COMPLETED
A Study to Compare Efficacy and Safety of Nanogen's Darbepoetin Alfa With Aranesp® (Amgen) in the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis (CKD)
Nanogen Pharmaceutical Biotechnology Joint Stock Company n=214
NCT04036253 COMPLETED
Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease
Bio Sidus SA n=43
NCT05196347 COMPLETED
Dapagliflozin and Renal Surrogate Outcomes in Advanced Chronic Kidney Disease
Kaohsiung Medical University n=180
NCT05075408 COMPLETED
To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus
Galderma R&D n=258
NCT05022329 TERMINATED
COVID-19 Vaccine Boosters in Patients With CKD
Sunnybrook Health Sciences Centre n=273
NCT04707768 COMPLETED
Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects
Akebia Therapeutics n=456
NCT06706271 COMPLETED
The Effect of Vitamin D3 Supplementation on Hepcidin and Ferritin Serum Levels in Children With Chronic Kidney Disease
Hasanuddin University n=43
NCT02988973 COMPLETED
A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia
Astellas Pharma Inc n=334
NCT02964936 COMPLETED
A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia
Astellas Pharma Inc n=100
NCT02780726 COMPLETED
A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia
Astellas Pharma Inc n=56
NCT02952092 COMPLETED
A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia
Astellas Pharma Inc n=303
NCT02780141 COMPLETED
A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia
Astellas Pharma Inc n=75
NCT05286853 WITHDRAWN
A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease
Prokidney
NCT05407389 SUSPENDED
Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study
Kibow Pharma n=600
NCT06016036 COMPLETED
SAL-0951 Tablets in the Treatment of Renal Anemia in Non-dialysis Chronic Kidney Disease
Shenzhen Salubris Pharmaceuticals Co., Ltd. n=156
NCT05342623 TERMINATED
A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Cara Therapeutics, Inc. n=286
NCT05356403 TERMINATED
CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Cara Therapeutics, Inc. n=105
NCT05425719 COMPLETED
Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects
MediBeacon n=249
NCT04456803 COMPLETED
Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Sinomune Pharmaceutical Co., Ltd n=239
NCT04741074 TERMINATED
Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
Geisinger Clinic n=15
NCT03534284 COMPLETED
Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis
University of Washington n=126
NCT04155125 COMPLETED
A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient
PT Kalbe Genexine Biologics n=391
NCT05180968 COMPLETED
DIalysis Symptom COntrol-Pruritus Outcome Trial
University of Manitoba n=14
NCT04727528 TERMINATED
Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease
AstraZeneca n=39
NCT02540993 COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease
Bayer n=5,734
NCT03289650 COMPLETED
Extended Release Tacrolimus vs. Twice-Daily Tacrolimus
Lorenzo Gallon n=29
NCT03902691 COMPLETED
Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis
Jiangsu Hansoh Pharmaceutical Co., Ltd. n=372
NCT03649711 COMPLETED
Chronic Kidney Disease (CKD) Platelet Study
University of Arkansas n=76
NCT02945969 COMPLETED
Sodium Lowering and Urinary Protein Reduction Trial
Tulane University School of Public Health and Tropical Medicine n=151
NCT04750460 COMPLETED
Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
Saint Petersburg State University, Russia n=20
NCT03315143 TERMINATED
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Lexicon Pharmaceuticals n=10,584
NCT03710291 TERMINATED
Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis
Tricida, Inc. n=1,480
NCT03806530 COMPLETED
DIalysis Symptom COntrol-Restless Legs Syndrome Trial
Population Health Research Institute n=52
NCT04410198 COMPLETED
Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants
Kyntra Bio n=203
NCT04484857 COMPLETED
Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants
Kyntra Bio n=283
NCT02865850 COMPLETED
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Akebia Therapeutics n=369
NCT04621331 WITHDRAWN
Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD
Kyntra Bio
NCT02892149 COMPLETED
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Akebia Therapeutics n=3,554
NCT02680574 COMPLETED
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Akebia Therapeutics n=1,725
NCT02648347 COMPLETED
Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease
Akebia Therapeutics n=1,751
NCT02620306 COMPLETED
A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan
Boryung Pharmaceutical Co., Ltd n=351
NCT02578394 COMPLETED
Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study
Mid and South Essex NHS Foundation Trust n=21
NCT04215120 COMPLETED
Desidustat in the Treatment of Anemia in CKD on Dialysis Patients
Zydus Lifesciences Limited n=392
NCT04012957 COMPLETED
Desidustat in the Treatment of Anemia in CKD
Zydus Lifesciences Limited n=588
NCT02273726 COMPLETED
Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis
Kyntra Bio n=741
NCT04764097 WITHDRAWN
Dapagliflozin Effect on Cardiovascular Outcomes in Haemodialysis for End Stage Renal Disease
Tan Tock Seng Hospital
NCT02545036 COMPLETED
Combined Western and Traditional Chinese Medicine Daycare for CKD Patients
China Medical University Hospital n=58
NCT04477811 COMPLETED
Comparative Study Evaluating the Effect of Vitamin K1 Versus Vitamin K2 on Vascular Calcification in Dialysis Patients
Ain Shams University n=40
NCT03036150 COMPLETED
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
AstraZeneca n=4,304
NCT03242252 COMPLETED
Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control
Lexicon Pharmaceuticals n=787
NCT03242018 COMPLETED
A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control
Lexicon Pharmaceuticals n=277
NCT03644264 COMPLETED
PA21 Safety and Efficacy in Adult Chinese Subjects
Vifor Fresenius Medical Care Renal Pharma n=286
NCT03551119 TERMINATED
Physical Activity in Renal Disease (PAIRED): The Effect on Hypertension
University of Alberta n=44
NCT03299244 COMPLETED
Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)
Amgen n=637
NCT04027517 COMPLETED
A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.
JW Pharmaceutical n=172
NCT03984760 COMPLETED
Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Panion & BF Biotech Inc. n=240
NCT02369549 COMPLETED
Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's n=518
NCT02521181 COMPLETED
The BASE Study: Bicarbonate Administration to Stabilize Estimated Glomerular Filtration Rate (eGFR)
Jennifer Gassman, PhD n=194
NCT02940860 COMPLETED
Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease
Pharmacosmos A/S n=1,538
NCT02341417 COMPLETED
Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis
Amgen n=28
NCT04361552 WITHDRAWN
Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)
Emory University
NCT02506868 COMPLETED
Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients
Biocad n=196
NCT02414841 COMPLETED
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
Proteon Therapeutics n=696
NCT02358343 COMPLETED
A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
University of Washington n=184
NCT03898622 COMPLETED
Supplementation of Thyroid Hormone for TSH Control in Patients With Chronic Kidney Disease Without TRR.
Hospital Civil de Guadalajara n=32
NCT03242967 WITHDRAWN
Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
Akebia Therapeutics
NCT02492620 COMPLETED
Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
Denver Nephrologists, P.C. n=200
NCT02504294 COMPLETED
A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis
Pfizer n=432
NCT03431623 COMPLETED
CKD-11101 Phase 3 SC Study
Chong Kun Dang Pharmaceutical n=248
NCT03428594 COMPLETED
CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis
Chong Kun Dang Pharmaceutical n=403

Data: ClinicalTrials.gov